Facebook
Linkedin
Mail
X
Youtube
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Search
Facebook
Linkedin
Mail
X
Youtube
Cardiovascular News
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Tag: PARTNER 3
TAVI holds up to SAVR at seven years on durability in PARTNER 3 trial
26th June 2026
Long-term follow-up d...
TCT 2025: TAVI continues to match up to surgery at seven years in PARTNER 3 trial
27th October 2025
Latest results from t...
TCT 2019: TAVI has sustained health status benefits over surgery for low-risk patients at one year, with similar five-year outcomes for intermediate-risk patients, unless via a transthoracic route
29th September 2019
A subanalysis of PART...
TVT 2019: TAVI is “preferred therapy” for low-risk patients
13th June 2019
This morning at TVT 2019 ...
